CoChat

Exosomal secretion of α-synuclein as protective mechanism after upstream blockage of macroautophagy

Open access

The DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.

Abstract

Accumulation of pathological α-synuclein aggregates plays a major role in Parkinson’s disease. Macroautophagy is a mechanism to degrade intracellular protein aggregates by wrapping them into autophagosomes, followed by fusion with lysosomes. We had previously shown that pharmacological activation of macroautophagy protects against α-synuclein-induced toxicity in human neurons. Here, we hypothesized that inhibition of macroautophagy would aggravate α-synuclein-induced cell death. Unexpectedly, inhibition of autophagosome formation by silencing of ATG5 protected from α-synuclein-induced toxicity. Therefore, we studied alternative cellular mechanisms to compensate for the loss of macroautophagy. ATG5 silencing did not affect the ubiquitin–proteasome system, chaperone systems, chaperone-mediated autophagy, or the unfolded protein response. However, ATG5 silencing increased the secretion of α-synuclein via exosomes. Blocking exosomal secretion exacerbated α-synuclein-induced cell death. We conclude that exosomal secretion of α-synuclein is increased after impaired formation of autophagosomes to reduce the intracellular α-synuclein burden. This compensatory mechanism prevents α-synuclein-induced neuronal cell death.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41419-018-0816-2

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 ATG5 siRNA protects against α-Syn-induced toxicity. The effect of ATG5 siRNA on ATG5 expression, autophagosome formation, and α-Syn-induced toxicity was analyzed. a qRT-PCR for ATG5 in cells overexpressing α-Syn, in cells overexpressing α-Syn and transfected with control siRNA against GAPDH, cells overexpressing the control protein GFP, and cells overexpressing α-Syn and transfected with ATG5 siRNA, showing the silencing efficacy of ATG5 siRNA on the mRNA level. The dashed line shows ATG5 levels in naïve (untransduced, untransfected) cells as reference. b Representative Western blot for ATG5 protein in naïve control cells (Ctrl) and cells in the conditions reported in a. β-actin was used as loading control. c Quantification of ATG5 protein, normalized to β-actin, from Western blots as shown in b, showing the silencing efficacy of ATG5 siRNA on the protein level. d Representative Western blot for the autophagosome marker LC3B in naïve cells (Ctrl), and cells transfected with ATG5 siRNA, with or without chloroquine (Chl) treatment to block autophagosome–lysosome fusion. e Quantification of LC3B-II protein, normalized to β-actin, from individual Western blots as shown in d, showing that Chl increases LC3B-II in naïve cells more than in ATG5 siRNA treated cells. f Quantification of lactate dehydrogenase (LDH) released into the culture medium as measure for toxicity. Data are expressed as percentage of α-Syn. ATG5 silencing significantly reduced α-Syn-induced toxicity. Data in a, c, e, f are mean ± standard error from n ≥ 3 biological replicates. *p < 0.05, **p < 0.01, ***p < 0.001; one-way analysis of variance with Bonferroni’s post hoc test
Fig. 1 ATG5 siRNA protects against α-Syn-induced toxicity. The effect of ATG5 siRNA on ATG5 expression, autophagosome formation, and α-Syn-induced toxicity was analyzed. a qRT-PCR for ATG5 in cells overexpressing α-Syn, in cells overexpressing α-Syn and transfected with control siRNA against GAPDH, cells overexpressing the control protein GFP, and cells overexpressing α-Syn and transfected with ATG5 siRNA, showing the silencing efficacy of ATG5 siRNA on the mRNA level. The dashed line shows ATG5 levels in naïve (untransduced, untransfected) cells as reference. b Representative Western blot for ATG5 protein in naïve control cells (Ctrl) and cells in the conditions reported in a. β-actin was used as loading control. c Quantification of ATG5 protein, normalized to β-actin, from Western blots as shown in b, showing the silencing efficacy of ATG5 siRNA on the protein level. d Representative Western blot for the autophagosome marker LC3B in naïve cells (Ctrl), and cells transfected with ATG5 siRNA, with or without chloroquine (Chl) treatment to block autophagosome–lysosome fusion. e Quantification of LC3B-II protein, normalized to β-actin, from individual Western blots as shown in d, showing that Chl increases LC3B-II in naïve cells more than in ATG5 siRNA treated cells. f Quantification of lactate dehydrogenase (LDH) released into the culture medium as measure for toxicity. Data are expressed as percentage of α-Syn. ATG5 silencing significantly reduced α-Syn-induced toxicity. Data in a, c, e, f are mean ± standard error from n ≥ 3 biological replicates. *p < 0.05, **p < 0.01, ***p < 0.001; one-way analysis of variance with Bonferroni’s post hoc testCC BY · PubMed Central
Fig. 2 Potential cellular pathways to dispose of α-Syn aggregates. In macroautophagy, misfolded proteins and dysfunctional organelles are wrapped into a phagophore to form an autophagosome, which fuses with a lysosome to become an autolysosome for degradation of its content. ATG5 knockdown inhibits the formation of the phagophore. Chaperones support the physiological folding process of newly synthesized or misfolded proteins and target irreparably misfolded protein for degradation. The ubiquitin proteasome system (UPS), degrades misfolded proteins for proteasomal proteolysis after labeling them with a poly-ubiquitin chain by successive action of ubiquitin activation enzymes (E1, blue), ubiquitin conjugation enzymes (E2, blue), and ubiquitin ligases (E3, blue). For chaperone-mediated autophagy (CMA), HSC70 and a chaperone complex recognize a KFERQ-pentapeptide motif of a protein and bind LAMP-2A in the lysosomal membrane to target the protein for degradation by lysosomal proteases. The unfolded protein response (UPR) is activated by accumulation of unfolded or misfolded proteins in the endoplasmic reticulum via three stress sensors (EIF2AK3, IRE1α, ATF6). In its active form, EIF2AK3 can phosphorylate the α-subunit of EIF2A. This phosphorylation is leading to decreased rates of protein synthesis, which further leads to the translation of specific mRNAs, such as ATF4. IRE1α is known to activate the transcription factor XBP1. α-Syn can be released from cells into the extracellular space either as free protein or packed in exosomes formed in multivesicular bodies. ATG5 autophagy-related gene 5, LAMP-2A lysosome-associated membrane protein type 2A, HSC70 the heat shock cognate protein of 70 kDa, EIF2AK3 eukaryotic translation initiation factor 2 alpha kinase 3, EIF2A eukaryotic translation initiation factor 2A, ATF4 activating transcription factor 4, IRE1α inositol requiring enzyme 1α, XBP1 X-box-binding protein 1, ATF6 activating transcription factor 6
Fig. 2 Potential cellular pathways to dispose of α-Syn aggregates. In macroautophagy, misfolded proteins and dysfunctional organelles are wrapped into a phagophore to form an autophagosome, which fuses with a lysosome to become an autolysosome for degradation of its content. ATG5 knockdown inhibits the formation of the phagophore. Chaperones support the physiological folding process of newly synthesized or misfolded proteins and target irreparably misfolded protein for degradation. The ubiquitin proteasome system (UPS), degrades misfolded proteins for proteasomal proteolysis after labeling them with a poly-ubiquitin chain by successive action of ubiquitin activation enzymes (E1, blue), ubiquitin conjugation enzymes (E2, blue), and ubiquitin ligases (E3, blue). For chaperone-mediated autophagy (CMA), HSC70 and a chaperone complex recognize a KFERQ-pentapeptide motif of a protein and bind LAMP-2A in the lysosomal membrane to target the protein for degradation by lysosomal proteases. The unfolded protein response (UPR) is activated by accumulation of unfolded or misfolded proteins in the endoplasmic reticulum via three stress sensors (EIF2AK3, IRE1α, ATF6). In its active form, EIF2AK3 can phosphorylate the α-subunit of EIF2A. This phosphorylation is leading to decreased rates of protein synthesis, which further leads to the translation of specific mRNAs, such as ATF4. IRE1α is known to activate the transcription factor XBP1. α-Syn can be released from cells into the extracellular space either as free protein or packed in exosomes formed in multivesicular bodies. ATG5 autophagy-related gene 5, LAMP-2A lysosome-associated membrane protein type 2A, HSC70 the heat shock cognate protein of 70 kDa, EIF2AK3 eukaryotic translation initiation factor 2 alpha kinase 3, EIF2A eukaryotic translation initiation factor 2A, ATF4 activating transcription factor 4, IRE1α inositol requiring enzyme 1α, XBP1 X-box-binding protein 1, ATF6 activating transcription factor 6CC BY · PubMed Central
Fig. 3 α-Syn overexpression and ATG5 siRNA do not change ubiquitin levels. The effect of α-Syn overexpression and ATG5 siRNA on the level of ubiquitinated proteins as global measure for the activity of the ubiquitin–proteasome system was analyzed in the absence and presence of the proteasome inhibitor MG132. a Representative Western blot for ubiquitin in naïve control cells (Ctrl), cells overexpressing α-Syn, cells overexpressing the control protein GFP, cells overexpressing α-Syn, and treated with ATG5 siRNA, and naïve cells treated with ATG5 siRNA. β-actin was used as loading control. b Quantification of ubiquitin, normalized to β-actin, from Western blots as shown in a. α-Syn overexpression, GFP overexpression, and ATG5 knockdown did not alter the global level of ubiquitinated proteins, neither with or without additional proteasome inhibition. Data in b are mean ± standard error from n = 3 biological replicates. n.s., not significant, one-way analysis of variance with Bonferroni’s post hoc test
Fig. 3 α-Syn overexpression and ATG5 siRNA do not change ubiquitin levels. The effect of α-Syn overexpression and ATG5 siRNA on the level of ubiquitinated proteins as global measure for the activity of the ubiquitin–proteasome system was analyzed in the absence and presence of the proteasome inhibitor MG132. a Representative Western blot for ubiquitin in naïve control cells (Ctrl), cells overexpressing α-Syn, cells overexpressing the control protein GFP, cells overexpressing α-Syn, and treated with ATG5 siRNA, and naïve cells treated with ATG5 siRNA. β-actin was used as loading control. b Quantification of ubiquitin, normalized to β-actin, from Western blots as shown in a. α-Syn overexpression, GFP overexpression, and ATG5 knockdown did not alter the global level of ubiquitinated proteins, neither with or without additional proteasome inhibition. Data in b are mean ± standard error from n = 3 biological replicates. n.s., not significant, one-way analysis of variance with Bonferroni’s post hoc testCC BY · PubMed Central
Fig. 4 α-Syn-induced increase in HSP27 is prevented by ATG5 siRNA. The effect of α-Syn overexpression and ATG5 siRNA on the level of chaperones was analyzed in naïve control cells (Ctrl), cells overexpressing α-Syn, cells overexpressing the control protein GFP, cells overexpressing α-Syn and treated with ATG5 siRNA, and naïve cells treated with ATG5 siRNA. β-actin was used as loading control. a Representative Western blot for HSP27. b Quantification of HSP27, normalized to β-actin, from Western blots as shown in a, showing an α-Syn-induced HSP27 increase, which is prevented by ATG5 siRNA. c Representative Western blot for HSP70. d Quantification of HSP70, normalized to β-actin, from Western blots as shown in c, showing stable expression across the experimental conditions. e Representative Western blot for HSP90. f Quantification of HSP90, normalized to β-actin, from Western blots as shown in e, showing stable expression across the experimental conditions. Data in b, d, f are mean ± standard error from n ≥ 3 biological replicates. n.s., not significant, **p < 0.01, ***p < 0.001; one-way analysis of variance with Bonferroni’s post hoc test
Fig. 4 α-Syn-induced increase in HSP27 is prevented by ATG5 siRNA. The effect of α-Syn overexpression and ATG5 siRNA on the level of chaperones was analyzed in naïve control cells (Ctrl), cells overexpressing α-Syn, cells overexpressing the control protein GFP, cells overexpressing α-Syn and treated with ATG5 siRNA, and naïve cells treated with ATG5 siRNA. β-actin was used as loading control. a Representative Western blot for HSP27. b Quantification of HSP27, normalized to β-actin, from Western blots as shown in a, showing an α-Syn-induced HSP27 increase, which is prevented by ATG5 siRNA. c Representative Western blot for HSP70. d Quantification of HSP70, normalized to β-actin, from Western blots as shown in c, showing stable expression across the experimental conditions. e Representative Western blot for HSP90. f Quantification of HSP90, normalized to β-actin, from Western blots as shown in e, showing stable expression across the experimental conditions. Data in b, d, f are mean ± standard error from n ≥ 3 biological replicates. n.s., not significant, **p < 0.01, ***p < 0.001; one-way analysis of variance with Bonferroni’s post hoc testCC BY · PubMed Central
Fig. 5 α-Syn-induced increase in LAMP-2A is not changed by ATG5 siRNA. The effect of α-Syn overexpression and ATG5 siRNA on markers for chaperone-mediated autophagy was analyzed in naïve control cells (Ctrl), cells overexpressing α-Syn, cells overexpressing the control protein GFP, cells overexpressing α-Syn and treated with ATG5 siRNA, and naïve cells treated with ATG5 siRNA. β-actin was used as loading control. a Representative Western blot for LAMP-2A. b Quantification of LAMP-2A, normalized to β-actin, from Western blots as shown in a, showing an α-Syn-induced LAMP-2A increase, which was not changed by ATG5 siRNA. c Representative Western blot for HSC70. d Quantification of HSC70, normalized to β-actin, from Western blots as shown in c, showing stable expression across the experimental conditions. Data in b, d are mean ± standard error from n ≥ 3 biological replicates. n.s., not significant, ***p < 0.001; one-way analysis of variance with Bonferroni’s post hoc test
Fig. 5 α-Syn-induced increase in LAMP-2A is not changed by ATG5 siRNA. The effect of α-Syn overexpression and ATG5 siRNA on markers for chaperone-mediated autophagy was analyzed in naïve control cells (Ctrl), cells overexpressing α-Syn, cells overexpressing the control protein GFP, cells overexpressing α-Syn and treated with ATG5 siRNA, and naïve cells treated with ATG5 siRNA. β-actin was used as loading control. a Representative Western blot for LAMP-2A. b Quantification of LAMP-2A, normalized to β-actin, from Western blots as shown in a, showing an α-Syn-induced LAMP-2A increase, which was not changed by ATG5 siRNA. c Representative Western blot for HSC70. d Quantification of HSC70, normalized to β-actin, from Western blots as shown in c, showing stable expression across the experimental conditions. Data in b, d are mean ± standard error from n ≥ 3 biological replicates. n.s., not significant, ***p < 0.001; one-way analysis of variance with Bonferroni’s post hoc testCC BY · PubMed Central
Fig. 6 α-Syn-induced increases in EIF2AK3, pEIF2A, IRE1α, and pIRE1α are not changed by ATG5 siRNA. The effect of α-Syn overexpression and ATG5 siRNA on markers for unfolded protein response was analyzed in naïve control cells (Ctrl), cells overexpressing α-Syn, cells overexpressing the control protein GFP, cells overexpressing α-Syn and treated with ATG5 siRNA, and naïve cells treated with ATG5 siRNA. Representative Western blots for (a) the eukaryotic translation initiation factor 2 alpha kinase 3 (EIF2AK3), (c) phosphorylated EIF2A (pEIF2A), (e) inositol requiring enzyme 1α (IRE1α), (g) phosphorylated IRE1α (pIRE1α), (i) X-box-binding protein 1 (XBP1), and (k) activating transcription factor 6 (ATF6). β-actin was used as loading control. Quantification of (b) EIF2AK3, (d) pEIF2A, (f) IRE1α, (h) pIRE1α, (j) XBP1, and (l) ATF6, showing α-Syn-induced increases in EIF2AK3, pEIF2A, IRE1α, and pIRE1α, which were not significantly changed by ATG5 siRNA. Data in b, d, f, h, j, l, are mean ± standard error from n ≥ 3 biological replicates. n.s., not significant, *p < 0.05, ***p < 0.001; one-way analysis of variance with Bonferroni’s post hoc test
Fig. 6 α-Syn-induced increases in EIF2AK3, pEIF2A, IRE1α, and pIRE1α are not changed by ATG5 siRNA. The effect of α-Syn overexpression and ATG5 siRNA on markers for unfolded protein response was analyzed in naïve control cells (Ctrl), cells overexpressing α-Syn, cells overexpressing the control protein GFP, cells overexpressing α-Syn and treated with ATG5 siRNA, and naïve cells treated with ATG5 siRNA. Representative Western blots for (a) the eukaryotic translation initiation factor 2 alpha kinase 3 (EIF2AK3), (c) phosphorylated EIF2A (pEIF2A), (e) inositol requiring enzyme 1α (IRE1α), (g) phosphorylated IRE1α (pIRE1α), (i) X-box-binding protein 1 (XBP1), and (k) activating transcription factor 6 (ATF6). β-actin was used as loading control. Quantification of (b) EIF2AK3, (d) pEIF2A, (f) IRE1α, (h) pIRE1α, (j) XBP1, and (l) ATF6, showing α-Syn-induced increases in EIF2AK3, pEIF2A, IRE1α, and pIRE1α, which were not significantly changed by ATG5 siRNA. Data in b, d, f, h, j, l, are mean ± standard error from n ≥ 3 biological replicates. n.s., not significant, *p < 0.05, ***p < 0.001; one-way analysis of variance with Bonferroni’s post hoc testCC BY · PubMed Central
Fig. 7 α-Syn-induced exosomal secretion is further increased by ATG5 siRNA. The effect of α-Syn overexpression and ATG5 siRNA on the release of α-Syn from cells was analyzed by Western blot in the conditioned medium of naïve control cells (Ctrl), cells overexpressing α-Syn, cells overexpressing the control protein GFP, cells overexpressing α-Syn treated with ATG5 siRNA, and naïve cells treated with ATG5 siRNA with or without GW4869 inhibitor. Furthermore, the effect of ATG5 siRNA combined with exosome inhibition to LDH release was analyzed. a Representative Western blot for α-Syn protein in the medium, showing the monomer at 15 kDa and an oligomer at 35 kDa. The faint band at 50 kDa is unchanged across the experimental groups and considered to be nonspecific. b Quantification of α-Syn protein (15 kDa band) from Western blots as shown in a, showing release of α-Syn from α-Syn overexpressing cells, which is further increased by additional ATG5 siRNA. c Representative Western blot for intracellular α-Syn protein. β-actin was used as loading control. d Quantification of α-Syn protein from Western blots as shown in c, showing no significant effect of naïve control cells (Ctrl), cells overexpressing α-Syn, and cells overexpressing α-Syn treated with ATG5 siRNA with GW4869 inhibitor compared to respective control cells. Intracellular levels of α-Syn significantly increased upon overexpression by comparison to naïve cells. e Representative Western blot for the exosomal marker CD81 in the vesicle enriched fraction of the medium. f Quantification of CD81 protein from Western blots as shown in c, showing an increase in exosomes in the medium by ATG5 siRNA. A further inhibition of exosome biogenesis lead to a decrease in exosomes in the medium by ATG5 siRNA. g Representative Western blot for α-Syn in the vesicle enriched fraction. h Quantification of α-Syn protein from Western blots as shown in g, showing exosomal secretion of α-Syn from α-Syn overexpressing cells, which is further increased by additional ATG5 siRNA. Furthermore, an inhibition of exosome biogenesis lead to a decrease in exosomal secretion of α-Syn in the medium by ATG5 siRNA. i Representative Western blot for the exosomal marker CD81, showing the absence of exosomes in the vesicle-free fraction of the medium. j Representative Western blot for α-Syn in the vesicle-free fraction. k Quantification of α-Syn protein from Western blots as shown in j, showing release of free α-Syn from α-Syn overexpressing cells, which is not altered by additional ATG5 siRNA. Inhibition of exosome biogenesis together with inhibition of autophagosome formation by ATG5 siRNA increased release of free α-Syn in the medium. l Quantification of lactate dehydrogenase (LDH) released into the culture medium. Data are expressed as percentage of α-Syn. Naïve control cells and α-Syn overexpressing cells treated with GW4869 did not show elevated toxicity levels compared to respective control cells. ATG5 silencing combined with GW4869 treatment significantly increased α-Syn-induced toxicity. Data in b, d, f, h, k, l are mean ± standard error from n ≥ 3 biological replicates. n.s., not significant, *p < 0.05, **p < 0.01, ***p < 0.001; one-way analysis of variance with Bonferroni’s post hoc test
Fig. 7 α-Syn-induced exosomal secretion is further increased by ATG5 siRNA. The effect of α-Syn overexpression and ATG5 siRNA on the release of α-Syn from cells was analyzed by Western blot in the conditioned medium of naïve control cells (Ctrl), cells overexpressing α-Syn, cells overexpressing the control protein GFP, cells overexpressing α-Syn treated with ATG5 siRNA, and naïve cells treated with ATG5 siRNA with or without GW4869 inhibitor. Furthermore, the effect of ATG5 siRNA combined with exosome inhibition to LDH release was analyzed. a Representative Western blot for α-Syn protein in the medium, showing the monomer at 15 kDa and an oligomer at 35 kDa. The faint band at 50 kDa is unchanged across the experimental groups and considered to be nonspecific. b Quantification of α-Syn protein (15 kDa band) from Western blots as shown in a, showing release of α-Syn from α-Syn overexpressing cells, which is further increased by additional ATG5 siRNA. c Representative Western blot for intracellular α-Syn protein. β-actin was used as loading control. d Quantification of α-Syn protein from Western blots as shown in c, showing no significant effect of naïve control cells (Ctrl), cells overexpressing α-Syn, and cells overexpressing α-Syn treated with ATG5 siRNA with GW4869 inhibitor compared to respective control cells. Intracellular levels of α-Syn significantly increased upon overexpression by comparison to naïve cells. e Representative Western blot for the exosomal marker CD81 in the vesicle enriched fraction of the medium. f Quantification of CD81 protein from Western blots as shown in c, showing an increase in exosomes in the medium by ATG5 siRNA. A further inhibition of exosome biogenesis lead to a decrease in exosomes in the medium by ATG5 siRNA. g Representative Western blot for α-Syn in the vesicle enriched fraction. h Quantification of α-Syn protein from Western blots as shown in g, showing exosomal secretion of α-Syn from α-Syn overexpressing cells, which is further increased by additional ATG5 siRNA. Furthermore, an inhibition of exosome biogenesis lead to a decrease in exosomal secretion of α-Syn in the medium by ATG5 siRNA. i Representative Western blot for the exosomal marker CD81, showing the absence of exosomes in the vesicle-free fraction of the medium. j Representative Western blot for α-Syn in the vesicle-free fraction. k Quantification of α-Syn protein from Western blots as shown in j, showing release of free α-Syn from α-Syn overexpressing cells, which is not altered by additional ATG5 siRNA. Inhibition of exosome biogenesis together with inhibition of autophagosome formation by ATG5 siRNA increased release of free α-Syn in the medium. l Quantification of lactate dehydrogenase (LDH) released into the culture medium. Data are expressed as percentage of α-Syn. Naïve control cells and α-Syn overexpressing cells treated with GW4869 did not show elevated toxicity levels compared to respective control cells. ATG5 silencing combined with GW4869 treatment significantly increased α-Syn-induced toxicity. Data in b, d, f, h, k, l are mean ± standard error from n ≥ 3 biological replicates. n.s., not significant, *p < 0.05, **p < 0.01, ***p < 0.001; one-way analysis of variance with Bonferroni’s post hoc testCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 59 references

Research works printed but not linked: 1

  1. Lilienbaum, A. Relationship between the proteasomal system and autophagy. Int. J. Biochem. Mol. Biol. 4, 1–26 (2013).

Cited by

See all 161

Metadata

Authors
Fussi, N., Höllerhage, M., Chakroun, T., Nykänen, N.-P., Rösler, T. W., Koeglsperger, T., Wurst, W., Behrends, C., & Höglinger, G. U.
Affiliations
  • German Center for Neurodegenerative Diseases (DE)
  • Munich Cluster for Systems Neurology (DE)
Corresponding author
Höglinger, Günter U.
Venue
Cell Death & Disease
Published
2018-07-09
Volume
9
Issue
7
Pages
757-757
ISSN
2041-4889 (ISSN-L)
OpenAlex
W2836440195
Cited by
161
References
60
Citations by year
2026: 10 · 2025: 17 · 2024: 30 · 2023: 15 · 2022: 22 · 2021: 23 · 2020: 17 · 2019: 25 · 2018: 2
FWCI
11.38
Type
journal article
Language
en
Open access
Licence
Locations
  • Cell Death and Disease (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Open access LMU (Ludwid Maxmilian's Universitat Munchen) (submittedVersion, cc-by)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion, other-oa)
  • DZNE Pub (submittedVersion, other-oa)
  • PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion, cc-by)
Funders
  • Deutsche Forschungsgemeinschaft (HO2402/6‐2)
  • Bundesministerium für Bildung und Forschung (01EK1605A, 01KU1403A EpiPD, 01EK1605A HitTau, 01EK1605C, 031A430E, 01KU1403A)
  • NOMIS Stiftung
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
Keywords
alpha-synuclein, exosomes, macroautophagy, ATG5, autophagosome formation, Parkinson's disease, neuronal cell death, protein aggregate clearance, neuroprotection
MeSH terms
Autophagosomes, Autophagy, Cell Line, Humans, Blotting, Western, RNA, Small Interfering, alpha-Synuclein, Exosomes, Real-Time Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Exosomal secretion of α-synuclein as protective mechanism after upstream blockage of macroautophagy. https://app.cochat.ai/papers/10.1038/s41419-018-0816-2
The paper
Fussi, N., Höllerhage, M., Chakroun, T., Nykänen, N.-P., Rösler, T. W., Koeglsperger, T., Wurst, W., Behrends, C., & Höglinger, G. U. (2018). Exosomal secretion of α-synuclein as protective mechanism after upstream blockage of macroautophagy. Cell Death & Disease. https://doi.org/10.1038/s41419-018-0816-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.